Today: 13 May 2026
Browse Category

NASDAQ:INBX 24 October 2025

Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx’s ozekibart cut risk of progression or death by 52% in Phase 2 chondrosarcoma trial, doubling median progression-free survival to 5.52 months versus placebo. Shares of INBX jumped about 70% intraday and closed at $28.36 on Oct. 23, then surged another 75–80% after hours. Management plans a BLA filing in Q2 2026. Ozekibart also showed high response rates in colorectal and Ewing sarcoma cohorts.

Stock Market Today

  • W. P. Carey (WPC) Valuation and Share Price Momentum Analysis
    May 12, 2026, 9:44 PM EDT. W. P. Carey (WPC) has gained 4.3% in the past month and 15.2% year-to-date, with a one-year shareholder return of 31.7%, reflecting growing investor interest. The stock trades near its analyst price target of $74.83, suggesting it is about 10% undervalued, according to forecasts that anticipate cash flow growth from strategic asset reinvestments. The real estate investment trust (REIT) benefits from balance sheet management and high spreads between disposition and investment capitalization rates, enabling margin expansion. However, its outlook depends on ongoing access to attractive investment opportunities and stable tenant credit quality, which pose risks. Investors are advised to consider these factors and evaluate W. P. Carey in the context of infrastructure and income-focused stocks before making decisions.

Latest article

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

13 May 2026
Tech stocks led declines Tuesday after April CPI data showed consumer prices rose 0.6% for the month and 3.8% year-over-year, pushing Treasury yields higher and weighing on rate-cut hopes. Brent crude settled above $107, fueling inflation concerns. The S&P 500 slipped 11.88 points to 7,400.96, while the Nasdaq lost 185.92 to 26,088.20. Chip stocks fell sharply, with Qualcomm down 11% and Intel off 6.8%.
Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

13 May 2026
Karman Holdings shares closed up 6.2% at $62.48 on May 12, then fell 11% after hours following first-quarter results and a raised 2026 outlook. Q1 revenue jumped 51% to $151.2 million, net income reached $7.8 million, and backlog hit $1.0 billion. Adjusted EPS matched the $0.11 estimate. The company announced over $1 billion in new contingent demand commitments.
Velo3D Stock Jumps After Q1 Results Turn Margin Story Into a Real Test

Velo3D Stock Jumps After Q1 Results Turn Margin Story Into a Real Test

13 May 2026
Velo3D shares surged 24.7% to $17.53 in after-hours trading Tuesday after first-quarter revenue rose 48% to $13.8 million and net loss narrowed to $7.0 million. Gross margin improved to 17.2%. The company raised $50 million in April but remains loss-making, with a recent going-concern warning. Backlog stood near $30 million, with repeat orders above 70% of total.
Go toTop